Prevalence and Characteristics of Hypertension among CKD Patients in Sudan: A Systematic Review and Meta-analysis

Authors

  • Gasmelseed Ahmed
  • Ahmed A. Osman
  • Abdelraheem Ali
  • AbdAllah Basheer

Keywords:

CKD, Dialysis, End-Stage Renal Disease, Hypertension, Renal Failure, Sudan

Abstract

The rate of chronic kidney diseases (CKD) is increasing steadily in Sudan, and hypertension remains one of the most common coexisting conditions among the patients. In this meta-analysis, we aimed to answer the review question (what is the prevalence of hypertension among patients with advanced CKD in Sudan?). We applied a guidelines checklist for the literature search about the (PRISMA-P 2015). We searched Google Scholar, PubMed, Cochrane Library, Embase, and Medline electronic databases for all articles on CKD conducted in Sudan. Eventually, we identified 23 studies, and only eight were included in the final meta-analysis. Out of the eight articles, there is a total sample of 2682 patients who were presented and diagnosed with advanced stage CKD; among them, 864 were found to be hypertensive, and the overall pooled prevalent rate of hypertension was 32% (95% CI 25% to 39%) with 91% heterogeneity. The lowest rate of hypertension among patients diagnosed with CKD was falling in the range of (14%-21%). We assessed the heterogeneity among studies using the I2, T2, and Q statistics. The results showed a funnel plot with asymmetrical distribution for effect sizes. The literature and evidence-based data on CKD in Sudan are scarce. However, the eight studies reviewed revealed elevated odds of CKD among patients with hypertension. The burden of the increased rate of CKD associated with prevalent hypertension and DM is a call for authorities for urgent interventional response.

References

Organization WH. 2021. Hypertension. World Health Organization. August 25, 2021. Available from: https://www.who. int/news-room/fact-sheets/detail/hypertension.

Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016; 134(6): 441-50. doi: 10.1161 /CIRCULATIONAHA. 115.018912.

Mills KT, Stefanescu S, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16(4): 223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5.

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl(2011). 2022; 12(1): 7-11. doi: 10.1016/j.kisu.2021.11.003.

Tolossa T, Fetensa G, Regassa B, Yilma MT, Besho M, Fekadu G et al. Burden and Determinants of Chronic Kidney Disease Among Diabetic Patients in Ethiopia: A Systematic Review and Meta-Analysis. Public Health Rev. 2021; 42: 1603969. doi: 10.3389/phrs.2021.1603969.

Ghelichi-Ghojogh M, Fararouei M, Seif M, Pakfetrat M. Chronic kidney disease and its health-related factors: a case-control study. BMC Nephrol. 2022; 23(1): 24. doi: 10.1186/s12882-021-02655-w.

Levey AS, Eckardt K, Tsukamoto Y, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6): 2089-2100. doi: 10.1111/j.1523-1755.2005.00365.x.

Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S et al. Febuxostat therapy for patients with stage 3 CKD and asymptomatic Hyperuricemia: a randomized trial. Am J Kidney Dis. 2018; 72(6): 798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1.

Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management. JAMA. 2019; 322(13): 1294-1304. doi: 10.1001/jama.2019.14745.

American Kidney Fund. Stages of Kidney diseases. Available from: https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease.

Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R et al. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study. PLoS One. 2017; 12(5): e0176540. Doi: 10.1371/journal.pone. 0176540.

Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J et al. Lessons from 30 years' data of Korean end-stage renal disease registry, 1985-2015. Kidney Res Clin Pract. 2015; 34(3): 132-9. doi: 10.1016/j.krcp.2015.08.004. Epub 2015 Aug 20.

Charani E, Cunnington AJ, Yousif AH, Ahmed MS, Ahmed AEM, Babiker

S et al. In transition: current health challenges and priorities in Sudan. BMJ Glob Health. 2019; 4(4): e001723. doi: 10.1136/bmjgh-2019-001723.

Awadalla H, Elmak NE, El-Sayed EF, Almobarak AO, Elmadhoun WM, Osman M et al. Hypertension in Sudanese individuals and associated risk factors: the critical intersection between salt and sugar intake. Cardiovasc Diagn Ther. 2018; 8(4): 432-8. doi: 10.21037/cdt.2018.04.05.

Banaga ASI, Mohammed EB, Siddig RM, Salama DE, Elbashir SB, Khojali MO et al. Causes of end-stage renal failure among haemodialysis patients in Khartoum State/Sudan. BMC Res Notes. 2015; 8: 502. doi: 10.1186/s13104-015-1509-x.

Elsharif ME, Elsharif EG. Causes of end-stage renal disease in Sudan: A single-center experience. Saudi J Kidney Dis Transpl. 2011; 22(2): 373-6.

Khalafalla A, Fathelraman S. Factors affect chronic kidney disease in Gezira Region of Sudan. Munich Personal RePEc Archive. 29 August 2021. Available from: https://mpra.ub.uni-muenchen.de/109406/1/MPRA_paper_109406.pdf

Idris AA, Mohammed HI, Osman MI. Impact of Tobacco Use in the Etiology of Chronic Renal Failure among Sudanese Patients. Al-Kindy Coll Med J. 2022; 18(1): 13-17. doi: 10.47723/kcmj.v18il.786.

Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM et al. Relationship between Blood Pressure and Incident Chronic Kidney Disease in Hypertensive Patients. Clin J Am Soc Nephrol. 2011 Nov; 6(11): 2605-11. doi: 10.2215/CJN.02240311. Epub 2011 Sep 15.

Osman EM, Abboud OI, Danielson BG. Chronic Renal Failure in Khartoum, Sudan. Ups J Med Sci. 1987; 92(1): 65-73. doi: 10.3109/03009738709178679.

Abu-Aisha H, Elhassan A, Khamis A, Abu-Elmaali A. Chronic Kidney Disease in Police Forces Households in Khartoum, Sudan: Pilot Report. Arab J Nephrol Transpl. 2009; 2(2): 21-6. doi: 10.4314/ajnt.v2i2.58852.

Shigidi M, Ebrahim S, Karrar W. An analysis of patients with chronic kidney disease newly referred to a specialized renal service in Sudan. Afr J Nephrol. 2021; 24(1): 12-18. doi: 10.21804/24-1-4467.

Elamin AEM, Mohammed NAA, Modawe GA. Aetiology of End-Stage Renal Disease among Adult Sudanese Patients. Sudan J Med Sci. 2012; 7(4): 255-8.

Hussain AA, Elzubier AG, Ahmed MK. Target organ involvement in hypertensive patients in Eastern Sudan. J Human Hypertens. 1999; 13(1): 9-12. doi: 10.1038/sj.jhh.1000719.

Abdalla AA. Knowledge, attitude, and practice towards therapeutic lifestyle changes in the management of hypertension in Khartoum State. Cardiovasc J Afr. 2021 Jul-Aug; 32(4): 198-203. doi: 10.5830/CVJA-2021-011.

Babiker FA, Elkhalifa LA, Moukhyer ME. Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults. Cardiovasc J Afr. 2013 Aug; 24(6): 208-212. doi: 10.5830/CVJA-2013-035.

Downloads

Published

28-06-2024

How to Cite

1.
Ahmed G, A. Osman A, Ali A, Basheer A. Prevalence and Characteristics of Hypertension among CKD Patients in Sudan: A Systematic Review and Meta-analysis. J Liaq Uni Med Health Sci [Internet]. 2024 Jun. 28 [cited 2024 Dec. 22];23(02):90-5. Available from: http://121.52.154.205/index.php/jlumhs/article/view/1136